Cancer
Inhibition of Nucleotide Excision Repair Proteins Increases Efficacy of Alkylating Agents in Cancer Treatment
Researchers from Universite Claude Bernard Lyon 1 have made a significant discovery in the field of cancer treatment. According to their study, published in the journal Biochimica et Biophysica Acta, the inhibition of nucleotide excision repair (NER) proteins can increase the efficacy of alkylating agents used to treat various cancers.